Pharmaceutical Regulatory Affairs - R17
Pharmaceutical Regulatory Affairs - R17
Pharmaceutical Regulatory Affairs - R17
I YEAR - I Semester
S. Course
Subjects L T P C
No Code
1 17S11101 Good Regulatory Practices 4 - - 4
7 17S11107 Seminar/Assignment - - 7 4
Total 16 - 19 26
I YEAR II Semester
S. Course Subject L T P C
No Code
1 17S11201 Regulatory Aspects of Drugs& Cosmetics 4 - - 4
2 17S11202 Regulatory Aspects of Herbal& Biologicals 4 - - 4
Total 16 - 19 26
III SEMESTER
IV SEMESTER
Scope
This course is designed to impart fundamental knowledge on various Good Regulatory Practices
viz., cGMP, GLP, GALP and GDP for Pharmaceuticals, Cosmetics, Food & Nutraceuticals,
Medical devices, In-vitro Diagnostic Medical Devices (IVDs) and biological products and
understand the rationale behind these requirements and will propose ways and means of
complying with them.
Objectives
1. 12Hrs
Current Good Manufacturing Practices: Introduction, US cGMPPart 210 and Part 211.EC
Principles of GMP (Directive91/356/EEC) Article 6 to Article 14 and WHO cGMP
guidelinesGAMP-5; Medical device and IVDs Global Harmonization TaskForce(GHTF)
Guidance docs.
2
12HrsGood Laboratory Practices: Introduction, USFDA GLPRegulations (Subpart A to
Subpart K), Controlling the GLPinspection process, Documentation, Audit, goals of
LaboratoryQuality Audit, Audit tools, Future of GLP regulations, relevant ISOand Quality
Council of India(QCI) Standards
3 12Hrs
5 12Hrs
REFERENCES
1. Good Laboratory Practice Regulations, by Sandy Weinberg, Fourth EditionDrugs and the
Pharmaceutical Sciences, Vol.168
2. Good Pharmaceutical Manufacturing practice, Rational and compliance byJohn Sharp, CRC
Press
5. Laboratory Auditing for Quality and Regulatory compliance buDonaldC.Singer, Drugs and the
Pharmaceutical Sciences, Vol.150.
Scope
Objectives
1. 12Hrs
2 12Hrs
3 12Hrs
4 12Hrs
5 12Hrs
Product life cycle management: Prior Approval Supplement(PAS), Post Approval Changes
[SUPAC], Changes BeingEffected in 30 Days (CBE-30), Annual Report, Post
marketingReporting Requirements, Post approval Labeling Changes,Lifecycle Management,
FDA Inspection and Enforcement,Establishment Inspection Report (EIR), Warning Letters,
Recalls,Seizure and Injunctions. ISO Risk Management Standard
REFERENCES
4. Laboratory auditing for quality and regulatory compliance. Donald C.Singer, Raluca-loana
Stefan, Jacobus F. Van Staden. Taylor andFrancis (2005).
8. Corporate Culture and the Quality Organization By James W. Fairfield-Sonn, Quorum Books,
2001
11. Juran's Quality Handbook, Sixth Edition, Joseph M. Juran and JosephA. De Feo, ASQ
Publications
12. Root Cause Analysis, The Core of Problem Solving and CorrectiveAction, Duke Okes, 2009,
ASQ Publications
13. International Medical Device Regulators Forum (IMDRF) MedicalDevice Single Audit
Program (MDSAP)
JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY ANANTAPUR
Scope
This course is designed to impart the fundamental knowledge on the clinicaldevelopment process
of drugs, pharmaceuticals and Medical Devices, phasesand conduct of clinical trials and
research, regulations and guidance governingthe conduct of clinical research in India, USA and
EU. It prepares the studentsto learn in detail on various laws, legislations and guidance related to
safety,efficacy, ethical conduct and regulatory approval of clinical research.
Objectives
Upon completion of the course, the student shall be able to (know, do andappreciate)
History, origin and ethics of clinical and biomedical research and evaluation
Clinical drug, medical device development process and different types and phases of clinical
trials
Regulatory requirements and guidance for conduct of clinical trials and research
Theory 60 Hrs
1. 12Hrs
2 12Hrs
Ethics in Clinical Research:
NDA 505(b)(1) of the FD&C Act (Application for approval of a new drug)
NDA 505(b)(2) of the FD&C Act (Application for approval of a new drug that relies, at least
in part, on data not developed by the applicant)
ANDA 505(j) of the FD&C Act (Application for approval of a generic drug product)
FDA Guidance for Industry - Acceptance of Foreign Clinical Studies
FDA Clinical Trials Guidance Document: Good Clinical Practice
EU: Clinical Research regulations in European Union (EMA)
4 12Hrs
EU Directives 2001
EudraLex (EMEA) Volume 3 – Scientific guidelines for medicinal products for human use
EU Annual Safety Report (ASR)
Volume 9A – Pharmacovigilance for Medicinal Products for Human Use
EU MDD with respect to clinical research
ISO 14155
REFERENCES
2. HIPAA and Human Subjects Research: A Question and AnswerReference Guide By Mark
Barnes, JD, LLM and Jennifer Kulynych, JD,PhD
3. Principles and Practices of Clinical Research, Second Edition Edited byJohn I. Gallin and
Frederick P. Ognibene
4. Reviewing Clinical Trials: A Guide for the Ethics Committee; Johan PEKarlberg and Marjorie
A Speers; Karlberg, Johan PetterEinar, HongKong.
5. International Pharmaceutical Product Registration: Aspects of Quality,Safety and Efficacy;
Anthony C. Cartwright; Taylor & Francis Inc., USA.
6. New Drug Approval Process: The Global Challenge; Guarino, RichardA; Marcel Dekker Inc.,
NY.
7. FDA regulatory affairs: a guide for prescription drugs, medical devices,and biologics; Douglas
J. Pisano, David Mantus; CRC Press, USA
RECOMMENDED WEBSITES:
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm
6.
http://www.fda.gov/regulatoryinformation/legislation/FederalFoodDrugandCosmeticActFDCAct
/FDCActChapterVDrugsandDevices/ucm108125.htm
Scope
Objectives
Upon the completion of the course the student shall be able to:
Know different Acts and guidelines that regulate Drugs & Cosmetics, Medical Devices,
Biologicals & Herbals, and Food &Nutraceuticals industry in India.
Understand the approval process and regulatory requirements for Drugs & Cosmetics,
Medical Devices, Biologicals & Herbals, and Food &Nutraceuticals
THEORY 60 Hrs
1. 12Hrs
Biologicals & Herbals, and Food &NutraceuticalsActs and Rules (with latest amendments):
1. Drugs and Cosmetics Act 1940 and Rules 1945: DPCOand NPPA
2. Other relevant provisions (rules schedules andguidelines for approval of Drugs & Cosmetics,
MedicalDevices, Biologicals & Herbals, and Food &Nutraceuticals in IndiaOther relevant Acts:
Narcotics Drugs and PsychotropicSubstances Act; Medicinal and Toilet Preparations
(ExciseDuties) Act, 1955; Pharmacy Act, 1948; Drugs and MagicRemedies (Objectionable
Advertisements) Act, 1955; Preventionof Cruelty to Animals Act.
2 12Hrs
Regulatory requirements and approval procedures for Drugs& Cosmetics Medical Devices,
Biologicals & Herbals, andFood&NutraceuticalsCDSCO (Central Drug Standard Control
Organization) and StateLicensing Authority: Organization, Responsibilities
Rules, regulations, guidelines and standards for regulatory filing of Drugs & Cosmetics,
Medical Devices, Biologicals & Herbals, and Food &Nutraceuticals
Format and contents of Regulatory dossier filing Clinical trial/ investigations
3 12Hrs
Indian Pharmacopoeial Standards, BIS standards and ISO andother relevant standards
4 12Hrs
5 12Hrs
REFERENCES
1. Manual of Patent Practice & Procedure, 3rd Edition, by The Patent Officeof India
2. Patent Failure How Judges, Bureaucrats, and Lawyers put innovators atrisk by James Bessen
and Michael J. Meurer
3. Principles and Practice of Clinical Trial Medicine by Richard Chin andBruce Y. Lee
5. CPCSEA Guidelines for Laboratory Animal Facility by Committee for thepurpose of control
and supervision on experiments on animals (CPCSEA)
7. Guidance for Industry on Submission of Clinical Trial Application forEvaluating Safety and
Efficacy by CDSCO (Central Drug Standard ControlOrganisation)
Scope
This course is designed to impart the fundamental knowledge on the drugdevelopment process,
regulatory requirements for approval of new drugs, drugproducts and cosmetics in regulated and
semi-regulated countries. It preparesthe students to learn in detail on the regulatory requirements,
documentationrequirements, and registration procedures for marketing the drug products
andcosmetics in regulated and semi-regulated countries.
Objectives
1. 12Hrs
USA & CANADA: Organization structure and functions of FDA.Federal register and Code of
Federal Regulations (CFR), Historyand evolution of United States Federal, Food, Drug and
CosmeticAct (FFDCA), Hatch Waxman act and Orange book, Purple book,Drug Master Files
(DMF) system in US, Regulatory ApprovalProcess for Investigational New Drug (IND), New
DrugApplication (NDA), Abbreviated New Drug Application (ANDA),Supplemental New Drug
Application (SNDA); Regulatoryrequirements for Orphan drugs and Combination
Products,Changes to an approved NDA / ANDA. Regulatory considerationsfor manufacturing,
packaging and labeling of pharmaceuticals inUSA. Legislation and regulations for import,
manufacture,distribution and sale of cosmetics in USA and Canada.
2 12Hrs
European Union & Australia: Organization and structure of EMA& EDQM, General guidelines,
Active Substance Master Files(ASMF) system in EU, Content and approval process of
IMPD,Marketing Authorization procedures in EU (Centralized procedure,Decentralized
procedure, Mutual recognition procedure andNational Procedure). Regulatory considerations for
manufacturing,packaging and labeling of pharmaceuticals in EU, Eudralexdirectives for human
medicines, Variations &extensions,Compliance of European Pharmacopoeia (CEP)/ Certificate
of Suitability (CoS), Marketing Authorization (MA) transfers, Qualified Person (QP) in EU.
Legislation and regulations for import, manufacture, distribution and sale of cosmetics in
European Union& Australia.
3 12Hrs
Japan: Organization of the PMDA, Pharmaceutical Laws and regulations, types of registration
applications, DMF system in Japan, drug regulatory approval process, Regulatory considerations
for manufacturing, packaging and labeling of pharmaceuticals in Japan, Post marketing
surveillance in Japan. Legislation and regulations for import, manufacture, distribution and sale
of cosmetics in Japan
4 12Hrs
Emerging Market: Introduction, Countries covered, Study of the world map, study of various
committees across the globe (ASEAN, APEC, EAC, GCC, PANDRH, SADC)
WHO: WHO, GMP, Regulatory Requirements for registration of drugs and post approval
requirements in WHO through prequalification programme, Certificate of Pharmaceutical
Product(CoPP) - General and Country Specific (South Africa, Egypt, Algeria and Morocco,
Nigeria, Kenya and Botswana)
5 12Hrs
Legislation and regulations for import, manufacture, distributionand sale of cosmetics in Brazil,
ASEAN, CIS and GCC Countries.
REFERENCES:
1. Generic Drug Product Development, Solid Oral Dosage forms, LeonShargel and IsaderKaufer,
Marcel Dekker series, Vol.143
2. The Pharmaceutical Regulatory Process, Edited by Ira R. Berry MarcelDekker Series, Vol.144
3. The Pharmaceutical Regulatory Process, Second Edition Edited by Ira R.Berry and Robert P.
Martin, Drugs and the Pharmaceutical Sciences,Vol.185Informa Health care Publishers.
Sciences, Vol.190.
5. Guidebook for drug regulatory submissions / Sandy Weinberg. By JohnWiley& Sons. Inc.
9. Preparation and Maintenance of the IND Application in eCTD Format ByWilliam K. Sietsema
11.http://www.who.int/medicines/areas/quality_safety/regulation_legislation/ListMRAWebsites.
pdf
14. Building a Future with Brics: The Next Decade for Offshoring, MarkKobayashi-Hillary,
Springer
18. The Gulf Cooperation Council: A Rising Power and Lessons for ASEANby Linda Low and
Lorraine Carlos Salazar (Nov 22, 2010)
19. Doing Business in the Asean Countries, BalbirBhasin, Business ExpertPress ISBN:13:978-1-
60649-108-9
20. Realizing the ASEAN Economic Community: A ComprehensiveAssessment, Michael G
Plummer (Editor), Chia Siow Yue (Editor),Instute of South east asian studies, Singapore
JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY ANANTAPUR
Scope
Objectives
1. 12Hrs
2 12Hrs
3 12Hrs
4 12Hrs
5 12Hrs
Herbal Products: Quality, safety and legislation for herbalproducts in India, USA and European
Union.
REFERENCES
1. FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices,and Biologics,
Douglas J. Pisano , David S. Mantus ; Informa ,2008
2. Biological Drug Products: Development and Strategies; WeiWang ,Manmohan Singh ; wiley
,2013
4. www.who.int/biologicals/en
5. www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/
6. www.ihn-org.com
7. www.isbtweb.org
9. www.cdsco.nic.in
Scope
This course is designed to impart the fundamental knowledge on the medicaldevices and in vitro
diagnostics, basis of classification and product life cycle ofmedical devices, regulatory
requirements for approval of medical devices inregulated countries like US, EU and Asian
countries along with WHOregulations. It prepares the students to learn in detail on the
harmonizationinitiatives, quality and ethical considerations, regulatory and
documentationrequirements for marketing medical devices and IVDs in regulated countries.
Objectives
basics of medical devices and IVDs, process of development, ethical and quality
considerations
harmonization initiatives for approval and marketing of medical devices and IVDs
regulatory approval process for medical devices and IVDs in India, US, Canada, EU, Japan
and ASEAN
clinical evaluation and investigation of medical devices and IVDs
Theory 60 Hrs
1. 12Hrs
2 12Hrs
3 12Hrs
4 12Hrs
5 12Hrs
ASEAN, China & Japan: Medical Devices and IVDs, Regulatoryregistration procedures, Quality
System requirements and clinicalevaluation and investigation.IMDRF study groups and guidance
documents.
REFERENCES
1. FDA regulatory affairs: a guide for prescription drugs, medical devices, andbiologics by
Douglas J. Pisano, David Mantus.
Scope
It prepares the students to learn in detail on Regulatory Aspects for nutraceuticals and food
supplements.
Objectives
1. 12Hrs
2 12Hrs
Global Aspects: WHO guidelines on nutrition. NSF International: Its Role in the Dietary
Supplements and Nutraceuticals Industries, NSF Certification, NSF Standards for Food And
Dietary Supplements. Good Manufacturing Practices for Nutraceuticals.
3 12Hrs
India : Food Safety and Standards Act, Food Safety and Standards Authority of India:
Organization and Functions, Regulations for import, manufacture and sale of nutraceutical
products in India, Recommended Dietary Allowances (RDA) in India.
4 12Hrs
USA: US FDA Food Safety Modernization Act, Dietary Supplement Health and Education Act.
U.S. regulations for manufacture and sale of nutraceuticals and dietary supplements, Labelling
Requirements and Label Claims for Dietary Supplements, Recommended Dietary Allowances
(RDA) in the U.S
5 12Hrs
European Union: European Food Safety Authority (EFSA): Organization and Functions. EU
Directives and regulations for manufacture and sale of nutraceuticals and dietary supplements.
Nutrition labelling. European Regulation on Novel Foods and Novel Food Ingredients.
Recommended Dietary Allowances (RDA) in Europe.
REFERENCES
2. Nutraceutical and Functional Food Regulations in the United States andAround the World by
DebasisBagchi (Academic Press, Elsevier)
3. http://www.who.int/publications/guidelines/nutrition/en/
4.
http://www.europarl.europa.eu/RegData/etudes/STUD/2015/536324/IPOL_STU(2015)536324_
EN.pdf
6. Food Regulation: Law, Science, Policy and Practice by Neal D. Fortin (Wiley)
1. Case studies on
2. Change Management/ Change control. Deviations
3. Corrective & Preventive Actions (CAPA)
4. Documentation of raw materials analysis as per official monographs
5. Preparation of audit checklist for various agencies
6. Preparation of submission to FDA using eCTD software
7. Preparation of submission to EMA using eCTD software
8. Preparation of submission to MHRA using eCTD software
9. Preparation of Biologics License Applications (BLA)
10. Preparation of documents required for Vaccine Product Approval
11. Comparison of clinical trial application requirements of US, EU andIndia of Biologics
JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY ANANTAPUR
UNIT – I
UNIT – II
Biostatistics: Definition, application, sample size, importance of sample size, factors influencing
sample size, dropouts, statistical tests of significance, type of significance tests, parametric
tests(students “t” test, ANOVA, Correlationcoefficient, regression), non-parametric tests
(wilcoxan rank tests, analysis of variance, correlation, chi square test), null hypothesis, P values,
degree of freedom, interpretation of P values.
UNIT – III
UNIT – IV
CPCSEA guidelines for laboratory animal facility: Goals, veterinary care, quarantine,
surveillance, diagnosis, treatment and control of disease, personal hygiene, location of animal
facilities to laboratories, anesthesia, euthanasia, physical facilities, environment, animal
husbandry, record keeping, SOPs, personnel and training, transport of lab animals.
UNIT – V
Declaration of Helsinki: History, introduction, basic principles for all medical research, and
additional principles for medical research combined with medical care.
References